| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/14/2009 | WO2009059422A1 Rotavirus vaccine |
| 05/14/2009 | WO2009042910A9 Ship inhibition to direct hematopoietic stem cells and induce extramedullary hematopoiesis |
| 05/14/2009 | WO2009042677A3 Stat3 inhibiting compositions and methods |
| 05/14/2009 | WO2009036084A3 Adhering troches with topically active ingredients for treatment of throat, esophagus, and stomach |
| 05/14/2009 | WO2009027830A3 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells |
| 05/14/2009 | WO2008100292A3 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 05/14/2009 | WO2008037458A8 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening |
| 05/14/2009 | WO2007058934A3 Methods and compositions for treating basement membrane disorders |
| 05/14/2009 | US20090124777 Compositions for Delivering Nucleic Acids to Cells |
| 05/14/2009 | US20090124568 Use of stem cells to generate inner ear cells |
| 05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |
| 05/14/2009 | US20090124009 Antisense modulation of ptp1b expression |
| 05/14/2009 | US20090123991 Retrons for gene targeting |
| 05/14/2009 | US20090123544 Stimulus-responsive biodegradable polymers and methods of preparation |
| 05/14/2009 | US20090123533 Compositions and methods for cancer diagnosis and therapy |
| 05/14/2009 | US20090123490 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 05/14/2009 | US20090123462 Fgfr agonists |
| 05/14/2009 | US20090123444 delivering a therapeutic agent to a solid tumor characterized by hypoxia, acidosis and hypertonicity comprising loading the therapeutic agent into sickle red blood cells; tissue targeted therapy; drug delivery |
| 05/14/2009 | US20090123440 using gutless adenovirus vector; gene therapy; gutless means incapable of expressing any adenovirus antigens; atherosclerosis |
| 05/14/2009 | US20090123438 Multivalent Vaccines Comprising Recombinant Viral Vectors |
| 05/14/2009 | US20090123426 Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same |
| 05/14/2009 | US20090123414 Il-15 Antigen Arrays And Uses Thereof |
| 05/14/2009 | CA2705325A1 Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair |
| 05/14/2009 | CA2704560A1 Use of oligonucleotides with modified bases in hybridization of nucleic acids |
| 05/14/2009 | CA2704236A1 Nucleic acid complex and nucleic acid delivery composition |
| 05/13/2009 | EP2058658A2 Method and means for influencing intercellular communication and intercellular organelle transport |
| 05/13/2009 | EP2058401A1 Widespread gene delivery to motor neurons using peripheral injection of AAV vectors |
| 05/13/2009 | EP2058395A1 Kif-derived peptide capable of binding to hla-a24 molecule |
| 05/13/2009 | EP2058329A1 Improved secretion of neublastin |
| 05/13/2009 | EP2057268A1 A dna vaccine for curing chronic hepatitis b and a method of preparing same |
| 05/13/2009 | EP2057178A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 05/13/2009 | EP2056882A2 Identification of a micro-rna that activates expression of beta-myosin heavy chain |
| 05/13/2009 | EP2056880A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 05/13/2009 | EP1490490B1 Antisense iap nucleobase oligomers and uses thereof |
| 05/13/2009 | EP1478778B1 Method and nucleic acids for the analysis of a colon cell proliferactive disorder |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | EP1135514B1 E1b-deleted adenoviral shuttle vectors |
| 05/13/2009 | EP0914325B1 Modulators of the function of fas receptors and other proteins |
| 05/13/2009 | CN101432432A Exosome transfer of nucleic acids to cells |
| 05/13/2009 | CN101432291A Chimeric adenoviral vectors |
| 05/13/2009 | CN101432026A Treatment of tendinopathy by inhibition of molecules that contribute to cartilage formation |
| 05/13/2009 | CN101429525A Antineoplastic invasion transfer function of snake venom metalloprotease inhibitors BJ46a and uses thereof |
| 05/13/2009 | CN101429523A Type T non--viral vector and composite medicament containing the same |
| 05/13/2009 | CN101429260A Polymethacrylate, preparation method and application thereof |
| 05/13/2009 | CN101429236A Type II non-structural protein 2B of dengue virus, recombinant expression vector, preparation and uses thereof |
| 05/13/2009 | CN100487125C Recombinant adeno-associated virus comprising VEGFR Truncated Soluble cDNA and gene therapeutic agent comprising the same |
| 05/13/2009 | CN100487124C Adeno-associated virus mediating trigenic cell expression system |
| 05/13/2009 | CN100487123C Method for coustructing shRNA expression carrier for inhibiting N-acetylglucosamine transferase V and its use |
| 05/13/2009 | CN100486995C Compositions and methods for WT1 specific immunotherapy |
| 05/13/2009 | CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 05/12/2009 | US7531714 Non-human transgenic animals as model study for human pathologies, being transgenic for having altered melusin expression; the non-human transgenic animals are to be used to study heart pathologies and provide therapies thereof, wherein heart pathologies are heart failure, and diluted cardiomyopathy |
| 05/12/2009 | US7531648 Gene therapy |
| 05/12/2009 | US7531647 Expression vector comprising nucleotide sequences coding fusion protein comprising HIV preintegration protein Vpr attached to amino or carboxy terminus of the Cre recombinase for use as genetic transfer tool in gene therapeutics |
| 05/12/2009 | US7531635 Monoclonal antibodies or functional fragment; immunoassay kit; female fertility diagnosis; Premature ovarian failure |
| 05/12/2009 | US7531629 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531515 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence |
| 05/12/2009 | US7531353 Non self-inactivating, expression targeted retroviral vectors |
| 05/12/2009 | US7531352 Inducible plasmid vector encoding TGF-β and use thereof |
| 05/12/2009 | US7531322 Using tissue specific gene transfer element as tool in somatic gene therapy |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531180 Chimeric alphavirus replicon particles |
| 05/12/2009 | US7531176 Brachyspira pilosicoli 72 kDa outer-membrane protein and diagnostic and therapeutic uses thereof |
| 05/12/2009 | US7531167 Herpes simplex virus vector |
| 05/12/2009 | CA2272338C Immunization of infants |
| 05/12/2009 | CA2213254C Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 05/07/2009 | WO2009059298A2 Compositions and methods of enhancing immune responses to eimeria |
| 05/07/2009 | WO2009059201A2 Id2 as a target in colorectal carcinoma |
| 05/07/2009 | WO2009058893A2 Preventing hyaluronan-mediated tumorigenetic mechanisms using intronic rnas |
| 05/07/2009 | WO2009058818A2 Compositions comprising a micro-rna and methods of their use in regulating cardiac remodeling |
| 05/07/2009 | WO2009058766A2 Methods of regulating the expression of mir-34a and p18ink4c |
| 05/07/2009 | WO2009058012A1 Means and methods for eliciting an immune response |
| 05/07/2009 | WO2009057812A1 Organic-inorganic hybrid nano particle composed of nucleic acid conjugate having polyethylene glycol bound thereto and calcium phosphate |
| 05/07/2009 | WO2009056671A1 Method for inhibiting angiogenesis or for treatment of cancer |
| 05/07/2009 | WO2009042642A3 Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer |
| 05/07/2009 | WO2009020645A3 Matriptase protein and uses thereof |
| 05/07/2009 | WO2009012176A3 Methods and compositions for treating brain diseases |
| 05/07/2009 | WO2008085564A3 Compositions and methods involving truncated recombinant seven g-protein coupled receptors |
| 05/07/2009 | WO2008073856A3 Delivery of nanoparticles and/or agents to cells |
| 05/07/2009 | WO2007051063A3 Gpcr expressing cell lines and antibodies |
| 05/07/2009 | WO2006020727A3 Methods for treating cns disorders by administration of agents to the nasal cavity |
| 05/07/2009 | US20090118219 Flea gaba receptor subunit nucleic acid molecules |
| 05/07/2009 | US20090118212 Methods for producing and using in vivo pseudotyped retroviruses |
| 05/07/2009 | US20090118210 Epididymal lipocalin gene and uses thereof |
| 05/07/2009 | US20090118209 Use of the slug gene as a genetic marker in functions mediated by SCF (stem cell factor) and applications |
| 05/07/2009 | US20090118206 Rna interference for the treatment of gain-of-function disorders |
| 05/07/2009 | US20090118205 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and uses Thereof in the Treatment of Cancer |
| 05/07/2009 | US20090118187 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118166 Conditioned Decellularized Native Tissues for Tissue Restoration |
| 05/07/2009 | US20090117565 Compositions and methods for diagnosis and treating mood disorders |
| 05/07/2009 | US20090117119 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 05/07/2009 | US20090117078 Crosslinked compounds and methods of making and using thereof |
| 05/07/2009 | US20090117046 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 05/07/2009 | CA2739011A1 Osteoarthritis gene therapy |
| 05/07/2009 | CA2704422A1 Compositions and methods of enhancing immune responses to eimeria |
| 05/07/2009 | CA2704418A1 A novel gene therapy approach for treating the metabolic disorder obesity |
| 05/07/2009 | CA2704383A1 Rationally-designed single-chain meganucleases with non-palindromic recognition sequences |
| 05/07/2009 | CA2704312A1 Means and methods for eliciting an immune response |
| 05/07/2009 | CA2704124A1 Method for inhibiting angiogenesis or for treatment of cancer |